Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of $0.45, versus $0.41 reported last year. Revenue for the quarter came in at $146.3 million, versus $151.8 million reported last year.

For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.